Axial Therapeutics announced that management will participate in a fireside chat at the 2020 RBC Capital Markets Healthcare Private...

Read more

Axial Biotherapeutics announced a $440,000 grant from the Michael J. Fox Foundation for Parkinsonā€™s Research to support its efforts...

Read more

Kairos Ventures portfolio company Axial Biotherapeutics announced the appointment of Dr. Gregory T. Bates as Senior Vice President of...

Read more
By: Kairos Ventures On: September 26, 2017 In: Axial Therapeutics, Portfolio News

We're excited to share that our portfolio company, Axial Biotherapeutics, has been selected as one of FierceBiotech's Fierce 15...

Read more

This month, Axial Biotherapeutics announced the appointment of leading experts in the Autism Spectrum Disorders (ASD) field to its...

Read more

Axial Biotherapeutics today announced the launch of the Company with a $19.15 million Series A round of financing. The...

Read more